Bottom line
BSVSX vs FCNTX: the short answer
BSVSX (Baird Equity Opportunity Fund) and FCNTX (Fidelity Contrafund) are both mutual funds.
But FCNTX is far broader, holding 441 positions to 36 for BSVSX, so beyond the top names it adds exposure BSVSX doesn't have.
FCNTX is cheaper at 0.74% vs 1.5% — a difference of $76 a year per $10,000 invested.
Over five years, FCNTX returned +15.5% a year vs +8.7% for BSVSX (reporting dates differ).
Updated Nov 19, 2026
BSVSX vs FCNTX side by side
| BSVSX | FCNTX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Baird | Fidelity |
| Category | Large Blend | Large Blend |
| Expense ratio | 1.5% | 0.74% |
| Annual cost per $10k | $150 | $74 |
| 10-yr cost on $10k (prospectus) | $2,160 | $918 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +2.7% | +21.8% |
| 5-yr return (annualized) | +8.7% | +15.5% |
| 10-yr return (annualized) | +7.6% | +16.9% |
| Best quarter | +27.6% | +26.9% |
| Worst quarter | −27.1% | −20.3% |
| Net assets (fund) | $77.2M | $180.0B |
| Number of holdings | 36 | 441 |
| Portfolio turnover | 69% | 29% |
| Returns as of | Dec 31, 2025 | Feb 28, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BSVSX and FCNTX share none of their top holdings.
BSVSX top 10
- First American Government Obli — 12.12%
- NCR Voyix Corp — 7.14%
- NeoGenomics Inc — 5.34%
- Sportradar Group AG — 5.27%
- RBC Bearings Inc — 5.15%
- HealthEquity Inc — 4.56%
- Norwegian Cruise Line Holdings — 4.45%
- Hayward Holdings Inc — 4.14%
- BILL Holdings Inc — 4.10%
- State Street SPDR S&P Biotech — 3.95%
FCNTX top 10
- Nvidia Corp — 9.34%
- Meta Platforms Inc — 6.96%
- Space Exploration Technologies Corp — 6.95%
- Amazon.com Inc — 5.75%
- Alphabet Inc — 4.24%
- Berkshire Hathaway Inc Del — 2.75%
- Apple Inc — 2.68%
- Alphabet Inc — 2.60%
- Broadcom Inc — 2.19%
- Microsoft Corp — 2.16%
FAQ
What is the difference between BSVSX and FCNTX?
Which is cheaper, BSVSX or FCNTX?
Should I own both BSVSX and FCNTX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.